In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supernus Pharmaceuticals Inc.

www.supernus.com

Latest From Supernus Pharmaceuticals Inc.

Deal Watch: Menarini Enters US Oncology Market Via Merger With Stemline

Menarini/Stemline, Supernus/US WorldMeds, BioMarin/DiNOAQOR, Adicet/ResTORbio, Vertex/Affinia, Hansoh/NiKang, plus COVID-19 deals in brief and more.

Deals Business Strategies

Deal Watch: Novartis Partners With TScan To Develop T-Cell Receptor-Targeted Therapies

Novartis/TScan and Gilead/Kite/oNKo-innate partnerships seek to advance cancer cell therapy. J&J, Bayer among the latest pharmas to unveil partnerships to fight the novel coronavirus.

Deals Business Strategies

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.

Approvals Drug Review

Supernus’ ADHD Drug Hits Phase III Endpoint As Filing Beckons

The first of two Phase III trials of Supernus’ ADHD candidate has hit its endpoints in adolescents. The second is due to report in early 2019, setting the stage for regulatory filings.

Clinical Trials Research & Development
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Pharmavene Inc.
  • Shire Laboratories Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Supernus Pharmaceuticals Inc.
  • Senior Management
  • Jack A Khattar, Pres. & CEO
    Gregory S Patrick, CFO
    Padmanabh P Bhatt, PhD, SVP, IP & CSO
    Victor Vaughn, SVP, Sales & Mktg.
    Stefan Schwabe, PhD, MD, CMO & EVP, R&D
    Tami T Martin, RN, SVP, Reg. Affairs
    Bryan A Rocklein, VP, Corp. Dev.
  • Contact Info
  • Supernus Pharmaceuticals Inc.
    Phone: (301) 838-2500
    1550 E. Gude Dr.
    Rockville, MD 20850
    USA
UsernamePublicRestriction

Register